We are live on ! Find out more
BTEC

Principal Exchange-Traded Funds Principal Healthcare Innovators ETF

Delisted

BTEC was delisted on the 31st of July, 2024.

31 hedge funds and large institutions have $94.5M invested in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

6% less funds holding

Funds holding: 3331 (-2)

15% less capital invested

Capital invested by funds: $112M → $94.5M (-$17.2M)

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
13
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change

BTEC Hedge Fund Activity: Q3 2021 in Review

31 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) for Q3 2021, worth a combined $94.5M — down 15% from $112M a quarter earlier.

Fund positioning in BTEC was balanced in Q3 2021: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 8 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $2.83M. The largest seller was Morgan Stanley, cutting an estimated $2.84M.

  • 31 institutional investors held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) as of Q3 2021, down from 33 in Q2 2021.
  • Funds reported $94.5M of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF stock for Q3 2021, down 15% quarter-over-quarter.
  • 5 funds opened new Principal Exchange-Traded Funds Principal Healthcare Innovators ETF positions in Q3 2021 and 5 closed out, a net change of 0 holders.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF buyer in Q3 2021 was Principal Financial Group, an estimated $2.83M added.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF seller in Q3 2021 was Morgan Stanley, an estimated $2.84M sold.

Based on aggregated 13F filings for Q3 2021.